Trypanosoma cruzi in nonischemic cardiomyopathy patients, houston, texas, usa

Melissa S. Nolan; David Aguilar; Arunima Misra; Sarah M. Gunter; Tim Erickson; Rodion Gorchakov; Hilda Rivera; Susan P. Montgomery; Kristy O. Murray

doi:10.3201/eid2707.203244

Trypanosoma cruzi in nonischemic cardiomyopathy patients, houston, texas, usa

Melissa S. Nolan, David Aguilar, Arunima Misra, Sarah M. Gunter, Tim Erickson, Rodion Gorchakov, Hilda Rivera, Susan P. Montgomery, Kristy O. Murray

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefi t from laboratory screening for T. cruzi infection.

Original language	English
Pages (from-to)	1958-1960
Number of pages	3
Journal	Emerging Infectious Diseases
Volume	27
Issue number	7
DOIs	https://doi.org/10.3201/eid2707.203244
State	Published - Jul 2021

Bibliographical note

Funding Information:
This project was funded by the National Institutes of Health, National Institute of Allergy and Infectious

Publisher Copyright:
© 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3201/eid2707.203244

Cite this

@article{f6ec2748e02d45dbb6a258030ce47061,

title = "Trypanosoma cruzi in nonischemic cardiomyopathy patients, houston, texas, usa",

abstract = "To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefi t from laboratory screening for T. cruzi infection.",

author = "Nolan, {Melissa S.} and David Aguilar and Arunima Misra and Gunter, {Sarah M.} and Tim Erickson and Rodion Gorchakov and Hilda Rivera and Montgomery, {Susan P.} and Murray, {Kristy O.}",

note = "Funding Information: This project was funded by the National Institutes of Health, National Institute of Allergy and Infectious Publisher Copyright: {\textcopyright} 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.",

year = "2021",

month = jul,

doi = "10.3201/eid2707.203244",

language = "English",

volume = "27",

pages = "1958--1960",

number = "7",

}

TY - JOUR

T1 - Trypanosoma cruzi in nonischemic cardiomyopathy patients, houston, texas, usa

AU - Nolan, Melissa S.

AU - Aguilar, David

AU - Misra, Arunima

AU - Gunter, Sarah M.

AU - Erickson, Tim

AU - Gorchakov, Rodion

AU - Rivera, Hilda

AU - Montgomery, Susan P.

AU - Murray, Kristy O.

N1 - Funding Information: This project was funded by the National Institutes of Health, National Institute of Allergy and Infectious Publisher Copyright: © 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.

PY - 2021/7

Y1 - 2021/7

N2 - To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefi t from laboratory screening for T. cruzi infection.

AB - To investigate possible cardiac manifestations of Chagas disease, we tested 97 Latinx patients with nonischemic cardiomyopathy in Houston, Texas, USA, for Trypanosoma cruzi infection. We noted a high prevalence of underdiagnosed infection and discrepant results in clinical diagnostic assays. Latinx cardiac patients in the United States would benefi t from laboratory screening for T. cruzi infection.

UR - http://www.scopus.com/inward/record.url?scp=85108625435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108625435&partnerID=8YFLogxK

U2 - 10.3201/eid2707.203244

DO - 10.3201/eid2707.203244

M3 - Article

C2 - 34152952

AN - SCOPUS:85108625435

VL - 27

SP - 1958

EP - 1960

IS - 7

ER -

Trypanosoma cruzi in nonischemic cardiomyopathy patients, houston, texas, usa

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this